medicineTower Capital and Temasek Holdings have joined company founders to submit a bid to take Singapore-listed traditional Chinese medicine firm Eu Yan Sang International private in a deal that values the company at S$269 million (US$196 million). The investment consortium is proposing to acquire the company's outstanding shares at S$0.60 per share, which represents a […]

Visit for more daily finance news, including audio and video Internet podcasts covering important investment news and financial events in China. Follow us on Twitter @chinamoneypod subscribe to all episodes on iTunes.

Visit the original source and full text: China Money Network